# Eli Lilly and Company (LLY) — Q2-2023 Earnings Results

**Report date:** 2023-08-08 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2023

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 14.87%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.11 | N/A | +6.57% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record for the earnings call, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Eli Lilly's earnings report showed a positive surprise in EPS, which likely contributed to the stock's significant increase of nearly 15%. Investors may be encouraged by the company's performance, even though revenue details were not disclosed. The lack of guidance may leave some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2023_